New Obesity Pill Shows Promising Results in Phase 1b Trial
The pharmaceutical industry's quest to dominate the lucrative market for new obesity medicines may face a formidable challenger in emerging biotech company Structure Therapeutics. According to initial data, Structure's obesity…